000756 新华制药
2025/06 - 中期
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资57,590-1.94%58,73058,57257,15456,707
投资性房地产30,214-4.98%31,79733,90948,35445,766
固定资产3,542,3760.88%3,511,4613,325,9453,447,8893,195,112
在建工程695,988-10.90%781,095730,545545,895562,959
无形资产542,570-3.98%565,038494,937474,107466,451
商誉0--0000
其他非流动资产376,8289.34%344,640327,925234,432251,080
5,245,567-0.89%5,292,7614,971,8334,807,8314,578,075

流动资产
货币资金1,275,0112.41%1,245,023918,3341,158,742744,662
应收账款1,095,96526.23%868,204699,878761,259658,568
存货1,228,936-3.45%1,272,8571,312,9841,211,9871,027,540
其他流动资产392,17515.09%340,756383,138324,971323,188
3,992,0877.12%3,726,8403,314,3343,456,9592,753,958

流动负债
短期借款252,926-56.40%580,156283,959118,023269,455
应付票据534,48120.34%444,140511,431491,025405,072
应付帐款786,61310.09%714,540666,413599,056661,320
其他流动负债1,578,17249.34%1,056,7791,024,1981,950,3821,166,034
3,152,19312.75%2,795,6142,486,0003,158,4862,501,880
流动资产净值839,894-9.81%931,226828,333298,474252,078
资产总额减流动负债6,085,461-2.23%6,223,9875,800,1665,106,3054,830,153

非流动负债
长期借款490,320-36.45%771,541799,400545,656346,197
应付债券0--0000
其他非流动负债230,149-2.04%234,946225,013211,085832,812
720,468-28.42%1,006,4871,024,413756,7411,179,008

总权益
    实收股本689,7771.08%682,408674,683669,627627,367
    储备项目4,436,9672.97%4,309,1813,878,4213,456,6472,840,574
股东权益5,126,7432.71%4,991,5894,553,1044,126,2743,467,942
非控股权益238,2495.46%225,912222,649223,290183,203